Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of selective serotonin reuptake inhibitors (SSRIs) and other central nervous system agents. Its structure supports the modulation of neurotransmitter activity, making it valuable in the creation of antidepressants and anxiolytic drugs. The presence of the difluoromethoxy group enhances metabolic stability and bioavailability, which improves drug efficacy. It is also employed in the preparation of bioactive molecules for research in neuropharmacology.